Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Biology and Treatment Strategy of AML in Its Subgroups: Multicenter Randomized Trial by the German Acute Myeloid Leukemia Cooperative Group (AMLCG) [Phase 3]
Phase 3 multicenter randomized trial by AMLCG on biology and treatment strategies for acute myeloid leukemia; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: Bendamustine in Acute Leukemia and MDS [Phase 1, Phase 2]
Phase 1/2 trial of bendamustine in acute leukemia and myelodysplastic syndromes was terminated with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: A Study of Decitabine in Combination With Escalating Doses of Rapamycin in Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
This Phase 1 trial investigates decitabine in combination with escalating doses of rapamycin in patients with relapsed or refractory acute m…
-
CLINICAL_TRIALS trial_result · 2012-09-17Clinical Trial Update: Safety and Efficacy Study of Ara-c at 18 gm/m2 Versus 12 gm/m2 for 3 Cycles Each in AML Consolidation [Phase 3]
Phase 3 clinical trial comparing Ara-C at 18 g/m2 vs 12 g/m2 for 3 cycles as consolidation in acute myeloid leukemia; current status is unkn…
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies [Phase 1]
Phase 1 dose-escalation study of CAL-101 in relapsed or refractory hematologic malignancies has completed, evaluating safety and preliminary…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2012-08-31Clinical Trial Update: PR104 in Treating Patients With Refractory/Relapsed Acute Leukemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for PR104 in patients with refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia, sp…
-
CLINICAL_TRIALS trial_result · 2012-08-27Clinical Trial Update: S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML [Phase 3]
Phase 3 trial S0106 in de novo acute myeloid leukemia comparing cytarabine and daunorubicin with or without gemtuzumab ozogamicin, followed …
-
CLINICAL_TRIALS trial_result · 2012-08-27Clinical Trial Update: Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia [Phase 3]
This Phase 3 trial evaluating chemotherapy with or without gemtuzumab ozogamicin in older patients with acute myeloid leukemia has completed…
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation [Phase 2]
Phase 2 trial of CEP-701 (lestaurtinib) in patients with refractory acute myeloid leukemia with FLT-3 mutation has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse [Phase 2]
Pfizer's CMA-676 was studied in older patients with acute myeloid leukemia in first relapse in a Phase 2 trial. The study status is complete…
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse [Phase 2]
Pfizer completed a Phase 2 trial of CMA-676 for treating patients with acute myeloid leukemia in first relapse.
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB) [Phase 1, Phase 2]
Clinical trial update on a reduced-intensity preparative regimen followed by stem cell transplantation (FAB) in several hematologic malignan…
-
CLINICAL_TRIALS trial_result · 2012-08-08Clinical Trial Update: Combination of Nilotinib (AMN107) and RAD001 in Patients With Acute Myeloid Leukemia [Phase 1, Phase 2]
A Phase 1/2 trial evaluated the combination of nilotinib and RAD001 (everolimus) in patients with acute myeloid leukemia; the study has comp…
-
CLINICAL_TRIALS trial_result · 2012-08-07Clinical Trial Update: Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome [Phase 2]
Phase 2 clinical trial evaluating chemotherapy followed by bone marrow transplantation in patients with acute myeloid leukemia or myelodyspl…
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: Effectiveness of Protected Environment Rooms for AML and MDS
Clinical trial update on the effectiveness of protected environment rooms for Acute Myeloid Leukemia and Myelodysplastic Syndrome; the study…
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS [Phase 1, Phase 2]
An allogeneic transplant regimen using Mylotarg with fludarabine and melphalan was studied for acute myeloid leukemia, chronic myeloid leuke…
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Patients
This update reports a completed clinical trial studying symptom-related cytokines in patients with acute myeloid leukemia and myelodysplasti…
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Gleevec/Low-Dose Ara-C Study for Elderly Patients With AML and Myelodysplastic Syndromes [Phase 2]
This is a completed Phase 2 clinical trial evaluating Gleevec (imatinib) in combination with low-dose cytarabine for elderly patients with a…
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
A completed clinical trial conducted at MD Anderson evaluated quality of life in patients with acute myeloid leukemia or myelodysplastic syn…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia [Phase 2]
Phase 2 trial evaluating peripheral stem cell transplantation with filgrastim in patients with acute or chronic myeloid leukemia; the study …
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Feasibility Study of Acute Myelogenous Leukemia mRNA Plus Lysate Loaded Dendritic Cell Vaccines [Phase 1]
Phase 1 feasibility study evaluating an mRNA plus lysate loaded dendritic cell vaccine for acute myeloid leukemia; the trial has been termin…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 1]
A Phase 1 clinical trial evaluating the combination of cytarabine and UCN-01 in patients with refractory or relapsed acute myeloid leukemia …
-
CLINICAL_TRIALS trial_result · 2012-07-26Clinical Trial Update: Safety Study of IL-7 in Recipients of a Hemopoietic Stem Cell Transplant Peripheral Blood Stem Cell Transplant [Phase 1]
Phase 1 safety study of interleukin-7 in recipients of a hematopoietic stem cell transplant (peripheral blood) has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-24Clinical Trial Update: Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia [Phase 2, Phase 3]
This entry reports an update on a Phase 2/Phase 3 clinical trial of gemtuzumab ozogamicin in older patients with previously untreated acute …
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a combination of clofarabine, cytarabine, and idarubicin in adults with intermediate- or high-risk acu…